The famed income investor Neil Woodford has put almost 8% of his flagship fund’s money into one company, AstraZeneca (LSE: AZN). Here are five reasons why he’s so confident that this investment will work out for him and his investors.
VIDEO: One Fool takes a closer look at AstraZeneca plc (LON:AZN).
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.
The famed income investor Neil Woodford has put almost 8% of his flagship fund’s money into one company, AstraZeneca (LSE: AZN). Here are five reasons why he’s so confident that this investment will work out for him and his investors.